| A review on exosomes application in clinical trials: perspective, questions, and challenges J Rezaie, M Feghhi, T Etemadi Cell Communication and Signaling 20 (1), 145, 2022 | 243 | 2022 |
| Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications R Rahbarghazi, N Jabbari, NA Sani, R Asghari, L Salimi, SA Kalashani, ... Cell Communication and Signaling 17, 1-17, 2019 | 168 | 2019 |
| Breast cancer‐derived exosomes: Tumor progression and therapeutic agents N Jabbari, E Akbariazar, M Feghhi, R Rahbarghazi, J Rezaie Journal of cellular physiology 235 (10), 6345-6356, 2020 | 100 | 2020 |
| Effect of multi-functional polyhydroxylated polyhedral oligomeric silsesquioxane (POSS) nanoparticles on the angiogenesis and exosome biogenesis in human umbilical vein … M Feghhi, J Rezaie, A Akbari, N Jabbari, H Jafari, F Seidi, S Szafert Materials & Design 197, 109227, 2021 | 44 | 2021 |
| The distinct roles of exosomes in innate immune responses and therapeutic applications in cancer J Rezaie, T Etemadi, M Feghhi European journal of pharmacology 933, 175292, 2022 | 29 | 2022 |
| Inhibitory effects of gallic acid on the activity of exosomal secretory pathway in breast cancer cell lines: A possible anticancer impact N Jabbari, M Feghhi, O Esnaashari, H Soraya, J Rezaie BioImpacts: BI 12 (6), 549, 2022 | 8 | 2022 |
| Bystander effects induced by electron beam-irradiated MCF-7 cells: A potential mechanism of therapy resistance M Feghhi, J Rezaie, K Mostafanezhad, N Jabbari Breast Cancer Research and Treatment 187 (3), 657-671, 2021 | 5 | 2021 |
| Exosomes as medicine: biomarkers, therapeutics, and vaccines J Rezaie, M Feghhi, T Etemadi | | 2023 |
Jafar RezaieAssistant Professor at Solid Tumor Research Center, Cellular and Molecular Medicine Institute在 umsu.ac.ir 的电子邮件经过验证
